To summarize data from the previous studies, polymorphisms in the NLRP3 gene and other inflammasome effectors have been linked to an increased susceptibility to IBD in general, but the impact and specific variants may vary in prevalence and severity between age groups. This evidence concerns the gene NLRP3 and inflammatory bowel disease.